Literature DB >> 3954551

Signs and symptoms of tobacco withdrawal.

J R Hughes, D Hatsukami.   

Abstract

To test the validity, magnitude, and clinical significance of the signs and symptoms of tobacco withdrawal defined by DSM-III, both observed and reported signs and symptoms were measured in 50 smokers during two days of ad lib smoking and then during the first four days of abstinence. Observer and subject ratings of the DSM-III symptoms of craving for tobacco, irritability, anxiety, difficulty concentrating, and restlessness increased after cessation. In addition, bradycardia, impatience, somatic complaints, insomnia, increased hunger, and increased eating occurred after cessation. The frequency and intensity of these symptoms varied across subjects; however, the average distress from tobacco withdrawal was similar to that observed in psychiatric outpatients. Subjects who had more withdrawal discomfort were more tolerant to the cardiovascular effects of nicotine. Subjects who had more withdrawal discomfort did not have a lower rate of smoking cessation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954551     DOI: 10.1001/archpsyc.1986.01800030107013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  651 in total

1.  Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive.

Authors:  J Sharfstein
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.

Authors:  J T Hays; I T Croghan; D R Schroeder; K P Offord; R D Hurt; T D Wolter; M A Nides; M Davidson
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

3.  One year effectiveness of an individualised smoking cessation intervention at the workplace: a randomised controlled trial.

Authors:  F Rodríguez-Artalejo; P Lafuente Urdinguio; P Guallar-Castillón; P Garteizaurrekoa Dublang; O Sáinz Martínez; J I Díez Azcárate; M Foj Alemán; J R Banegas
Journal:  Occup Environ Med       Date:  2003-05       Impact factor: 4.402

4.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

5.  Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Authors:  Thomas J Hopkins; Laura E Rupprecht; Matthew R Hayes; Julie A Blendy; Heath D Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 6.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

7.  Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse.

Authors:  Joseph W Ditre; Bryan W Heckman; Lisa R LaRowe; Jessica M Powers
Journal:  Nicotine Tob Res       Date:  2021-01-07       Impact factor: 4.244

8.  Measures and predictors of varenicline adherence in the treatment of nicotine dependence.

Authors:  Annie R Peng; Mark Morales; E Paul Wileyto; Larry W Hawk; Paul Cinciripini; Tony P George; Neal L Benowitz; Nicole L Nollen; Caryn Lerman; Rachel F Tyndale; Robert Schnoll
Journal:  Addict Behav       Date:  2017-07-12       Impact factor: 3.913

9.  Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.

Authors:  Lisa R LaRowe; Jesse D Kosiba; Emily L Zale; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

10.  Cigarette smoking and mental illness: a study of nicotine withdrawal.

Authors:  Philip H Smith; Gregory G Homish; Gary A Giovino; Lynn T Kozlowski
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.